banner
5'-O-DMTr-2'-O-methyl-N6-methyl adenosine 3'-CED phosphoramidite
Inquiry

Cat. No.: X25-06-LY867

5'-O-DMTr-2'-O-methyl-N6-methyl adenosine 3'-CED phosphoramidite

Synonym: 2348385-04-4; 3-[[(2R,3R,4R,5R)-2-[[Bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-methoxy-5-[6-(methylamino)purin-9-yl]oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile; 5'-O-DMTr-2'-O-Methyl-N6-methyl adenosine 3'-CED phosphoramidite; 5'-O-DMTr-2'-O-Me-N6-Me-adenosine 3'-CED phosphoramidite

  • CAS Number: 2348385-04-4
  • Compound CID: 167312661
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
5'-O-DMTr-2'-O-methyl-N6-methyl adenosine 3'-CED phosphoramidite is an isomer containing dimethyladenosine, with the 5'-terminal protected as DMTr.
Molecular Weight
797.88
Molecular Formula
C42H52N7O7P
Form
Solid
Purity
≥95.0%
Applications
5'-O-DMTr-2'-O-methyl-N6-methyl adenosine 3'-CED phosphoramidite can be used for designing RNA tags and studying the role of RNA modification in cell function and gene regulation.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0